skip to main |
skip to sidebar
NIH Funding Opportunities and Notices for 05-31-2019 (The NIH Guide TOC)
General Notices
Notice of Changes to Funding Opportunities
Notices of Special Interest
Funding Opportunities
- Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
(PAR-19-289)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 5, 2019.
- Exploratory Grant for NIA Alzheimers Disease Research Center (P20 Clinical Trial Not Allowed)(RFA-AG-20-023)
National Institute on Aging
Application Receipt Date(s): October 9, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
- Oscillatory Patterns of Gene Expression in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)
(RFA-AG-20-040)
National Institute on Aging
Application Receipt Date(s): October 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
- Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
(RFA-AI-19-042)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): September 16, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
- Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
(RFA-AI-19-043)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): September 16, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
- National Drug Early Warning System Coordinating Center (U01 Clinical Trial Optional )
(RFA-DA-20-016)
National Institute on Drug Abuse
Application Receipt Date(s): August 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
- Exploiting In Vivo Precision Pharmacology Techniques to Understand Opioid Receptor Signaling in Specific Circuits, Cell Types, and Subcellular Compartments (R61/R33 - Clinical Trial Not Allowed) (RFA-DA-20-019)
National Institute on Drug Abuse
Application Receipt Date(s): October 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
- Adipogenesis, Adipocyte Function and Obesity Following HIV Infection, Antiretroviral Therapy, or Pre-Exposure Prophylaxis (R01 Clinical Trial Optional)
(RFA-DK-19-008)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 7, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
- Implementation of U.S. Food Safety Modernization Act - Identifying, Researching, and Implementing Alternative Methods to Expand the Reach across the Global Supply Chain (U01) - Clinical Trials Not Allowed
(RFA-FD-19-022)
Food and Drug Administration
Application Receipt Date(s): July 29, 2019, Year(s), by 11:59 PM Eastern Time Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
- Renewal Application: Critical Path Public Private Partnerships (U18) Clinical Trials Optional
(RFA-FD-19-027)
Food and Drug Administration
Application Receipt Date(s): July 29, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
- Cigar Tobacco Reference Products Program (UC2) Clinical Trials Not Allowed
(RFA-FD-20-002)
Food and Drug Administration
Application Receipt Date(s): September 10, 2019 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
- Brain Initiative: Research to Develop and Validate Advanced Human Cell-Based Assays To Model Brain Structure and Function (R01 Clinical Trial Not Allowed)
(RFA-MH-20-140)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): November 1, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
- Research Program Award (R35 Clinical Trial Optional)
(RFA-NS-19-037)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): July 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
.png)
No hay comentarios:
Publicar un comentario